Role of TRPM8 in Cold-stored Platelet Transfusions

Information

  • Research Project
  • 10034869
  • ApplicationId
    10034869
  • Core Project Number
    R01HL153072
  • Full Project Number
    1R01HL153072-01
  • Serial Number
    153072
  • FOA Number
    PAR-18-126
  • Sub Project Id
  • Project Start Date
    8/1/2020 - 4 years ago
  • Project End Date
    6/30/2025 - 5 months from now
  • Program Officer Name
    EL KASSAR, NAHED
  • Budget Start Date
    8/1/2020 - 4 years ago
  • Budget End Date
    6/30/2021 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    01
  • Suffix
  • Award Notice Date
    7/31/2020 - 4 years ago
Organizations

Role of TRPM8 in Cold-stored Platelet Transfusions

PROJECT SUMMARY The detection of temperature change by nerve receptors in human tissues is a life?preserving function which is highly evolutionarily selected. Platelets show a unique response to cold with cytoskeletal rearrangement and low?level receptor activation. Temperature?gated transient receptor potential channels (Thermo TRPs) are a family of ion channels activated by temperature. Transient Receptor Potential Melastatin 8 (TRPM8) also known as Cold and Menthol Receptor 1 (CMR1), is a nonselective cation channel gated by cold?stimuli and various cooling reagents including menthol, eucalyptol, and icilin. In preliminary studies, we show that platelets express TRPM8, and the addition of TRPM8 agonists mimic typical morphologic and functional changes of platelets exposed to cold. The overarching goal of these studies is to characterize the molecular pathways through which platelets react to temperature changes. Further elucidating these mechanisms could lead to improved platelet storage conditions at 4ºC for transfusions, safer antiplatelet therapy, better prevention of heart attacks, and fewer side effects when therapeutic lowering of the body temperature after cardiac arrest is required. In aim 1 of this proposal, we will characterize the role of TRPM8 in platelets and elucidate its specific function for the cold platelet phenotype. This aim proposes to expand on our preliminary data that identified TRPM8 on human platelets and underscore its functional relevance. In aim 2 we will evaluate TRPM8 as a target for inhibition during platelet storage at 4ºC utilizing a small molecule TRPM8 inhibitor. In aim 3 of this proposal, we will determine the role of TRPM8 inhibition during 4ºC storage for recovery, survival, and function after transfusion in healthy human subjects.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
    290572
  • Indirect Cost Amount
    216707
  • Total Cost
    507279
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    839
  • Ed Inst. Type
  • Funding ICs
    NHLBI:507279\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BLOODWORKS
  • Organization Department
  • Organization DUNS
    092881085
  • Organization City
    SEATTLE
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    981041239
  • Organization District
    UNITED STATES